biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
Category
Uncategorized
18
Jan
Scope Fluidics S.A. moves to the Warsaw Stock Exchange (WSE) main market
18.01.2023
SCOPE FLUIDICS
Uncategorized
Read More
30
Jun
Scope Fluidics starts distribution of PCR|ONE system
30.06.2022
SCOPE FLUIDICS
Uncategorized
Read More
04
Aug
Bio-Rad Acquires Curiosity Diagnostics
04.08.2022
SCOPE FLUIDICS
Uncategorized
Read More
14
Sep
Forbes: Piotr Garstecki. Polish Professor Breaks the Bank
14.09.2022
SCOPE FLUIDICS
Uncategorized
Read More
14
Nov
Scope Fluidics reports excellent financial position
14.11.2022
SCOPE FLUIDICS
Uncategorized
Read More
16
Dec
Piotr Garstecki reaches TOP 3 in Forbes Poland magazine’s Polish Business Leader 2022 ranking
16.12.2022
SCOPE FLUIDICS
Uncategorized
Read More
13
Dec
Scope Fluidics among participants at J.P. Morgan Health Care Conference 2023
13.12.2022
SCOPE FLUIDICS
Uncategorized
Read More
31
Mar
Scope Fluidics begins certification clinical trials of SARS-CoV-2 panel adapted for scaled-up production
31.03.2022
SCOPE FLUIDICS
Uncategorized
Read More
28
Apr
Scope Fluidics S.A. completes certification clinical trials for its SARS-CoV-2 panel and commences certification clinical trials for its MRSA/MSSA panel
28.04.2022
SCOPE FLUIDICS
Uncategorized
Read More
11
Apr
Scope Fluidics extends the functionality of the BacterOMIC system diagnostic panel and begins its validation study
11.04.2022
SCOPE FLUIDICS
Uncategorized
Read More
1
…
5
6
7
8
9
…
14
Search
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments
Tag Cloud
home
Recent Comments